Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
Npj Viruses|March 20, 2026
SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemicCristina Gonzalez-Lopez, Muriel Aguilar-Bretones, Julian Reinders, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Npj Viruses|May 15, 2026
Hemagglutinin E190D substitution in clade 2.3.4.4b A(H5N1) influenza virus reduces receptor binding and viral fitnessXiangjie Sun, Claudia Lisboa, Paul J Carney, et al.
Npj Viruses|June 30, 2026
Structural and immunogenic characterisation of ChAdOx1 Chik-derived Chikungunya VLPs supports a mechanistic rationale for vaccine-induced protectionYoung Chan Kim, Xiyong Song, Yasunori Watanabe, et al.
Npj Viruses|July 7, 2026
MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccineesDavid da Fonseca Araújo, Christoph Schultheiß, Leon Cords, et al.
Npj Viruses|June 26, 2026
Single molecule super resolution microscopy reveals formation of Dengue NS2B3 cluster on mitochondrial network and its effect on fragmentationJiby M Varghese, Prakash Joshi, Aravinth S, et al.
Npj Viruses|August 26, 2026
Inhibition of KDM5A/B promotes antitumor innate immune responses in HHV-8/KSHV-positive B-cell lymphomasDawei Zhou, Guillaume N Fiches, Zhenyu Wu, et al.
Npj Viruses|September 25, 2026
In silico analysis of pH stabilising mutations of hemagglutinin of influenza A virus H5N1 clade 2.3.4.4bDaniel Christian Lauster, Christian Sieben, Matthias Ballauff, et al.
Npj Viruses|January 3, 2025
Modulating cytokine microenvironment during T cell activation induces protective RSV-specific lung resident memory T cells in early life in miceZiyin Wang, Miko Zhong, Chubicka Thomas, et al.
Npj Viruses|November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Pageof 20